Recently, a large multicenter clinicaltrial using atrial natriuretic peptide (ANP) at the time of myocardial reperfusionwith AMI was reported that ANP (carparitide) could reduce infarct size, improveejection fraction and decrease the rate of new-onset heart failure[23]. Here, NPPA is linked to heart failure.